50 related articles for article (PubMed ID: 30132846)
1. Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells.
Rodríguez-Hernández MA; González R; de la Rosa ÁJ; Gallego P; Ordóñez R; Navarro-Villarán E; Contreras L; Rodríguez-Arribas M; González-Gallego J; Álamo-Martínez JM; Marín-Gómez LM; Del Campo JA; Quiles JL; Fuentes JM; de la Cruz J; Mauriz JL; Padillo FJ; Muntané J
J Cell Physiol; 2018 Jan; 234(1):692-708. PubMed ID: 30132846
[TBL] [Abstract][Full Text] [Related]
2. Bufalin induces the interplay between apoptosis and autophagy in glioma cells through endoplasmic reticulum stress.
Shen S; Zhang Y; Wang Z; Liu R; Gong X
Int J Biol Sci; 2014; 10(2):212-24. PubMed ID: 24550689
[TBL] [Abstract][Full Text] [Related]
3. Autophagy and apoptosis cascade: which is more prominent in neuronal death?
Gupta R; Ambasta RK; Pravir Kumar
Cell Mol Life Sci; 2021 Dec; 78(24):8001-8047. PubMed ID: 34741624
[TBL] [Abstract][Full Text] [Related]
4. CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic Cell Death.
Ding B; Bao C; Jin L; Xu L; Fan W; Lou W
Front Oncol; 2021; 11():681683. PubMed ID: 34249726
[TBL] [Abstract][Full Text] [Related]
5. Potential Antitumor Activity of Combined Lycopene and Sorafenib against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation.
El-Masry TA; El-Nagar MMF; El Mahdy NA; Alherz FA; Taher R; Osman EY
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675487
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis.
Méndez-Blanco C; Fernández-Palanca P; Fondevila F; González-Gallego J; Mauriz JL
Ther Adv Med Oncol; 2021; 13():1758835920987071. PubMed ID: 33613697
[TBL] [Abstract][Full Text] [Related]
7. Molecular Bases of Drug Resistance in Hepatocellular Carcinoma.
Marin JJG; Macias RIR; Monte MJ; Romero MR; Asensio M; Sanchez-Martin A; Cives-Losada C; Temprano AG; Espinosa-Escudero R; Reviejo M; Bohorquez LH; Briz O
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32585893
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma.
Qu L; Liu Y; Deng J; Ma X; Fan D
J Pharm Anal; 2023 May; 13(5):463-482. PubMed ID: 37305788
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic reticulum stress in diabetic kidney disease: adaptation and apoptosis after three UPR pathways.
Zhang R; Bian C; Gao J; Ren H
Apoptosis; 2023 Aug; 28(7-8):977-996. PubMed ID: 37285056
[TBL] [Abstract][Full Text] [Related]
10. Modified 5-aminolevulinic acid photodynamic therapy suppresses cutaneous squamous cell carcinoma through blocking Akt/mTOR-mediated autophagic flux.
Zeng Q; Liu J; Yan Y; Zhang G; Wang P; Zhang H; Liu X; Zhang L; Wang X
Front Pharmacol; 2023; 14():1114678. PubMed ID: 37007013
[No Abstract] [Full Text] [Related]
11. Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation.
Fernández-Palanca P; Payo-Serafín T; San-Miguel B; Méndez-Blanco C; Tuñón MJ; González-Gallego J; Mauriz JL
Acta Pharmacol Sin; 2023 May; 44(5):1066-1082. PubMed ID: 36376373
[TBL] [Abstract][Full Text] [Related]
12. Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy.
Zhang W; Yu G; Zhang H; Basyal M; Ly C; Yuan B; Ruvolo V; Piya S; Bhattacharya S; Zhang Q; Borthakur G; Battula V; Konopleva M; Rice WG; Andreeff M
Haematologica; 2023 Jun; 108(6):1500-1514. PubMed ID: 36226489
[TBL] [Abstract][Full Text] [Related]
13. miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.
de la Cruz-Ojeda P; Schmid T; Boix L; Moreno M; Sapena V; Praena-Fernández JM; Castell FJ; Falcón-Pérez JM; Reig M; Brüne B; Gómez-Bravo MA; Giráldez Á; Bruix J; Ferrer MT; Muntané J
Cells; 2022 Aug; 11(17):. PubMed ID: 36078082
[TBL] [Abstract][Full Text] [Related]
14. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma
Davidi S; Jacobovitch S; Shteingauz A; Martinez-Conde A; Braten O; Tempel-Brami C; Zeevi E; Frechtel-Gerzi R; Ene H; Dor-On E; Voloshin T; Tzchori I; Haber A; Giladi M; Kinzel A; Weinberg U; Palti Y
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740624
[TBL] [Abstract][Full Text] [Related]
15. The Role of Non-Coding RNAs in Autophagy During Carcinogenesis.
de la Cruz-Ojeda P; Flores-Campos R; Navarro-Villarán E; Muntané J
Front Cell Dev Biol; 2022; 10():799392. PubMed ID: 35309939
[TBL] [Abstract][Full Text] [Related]
16. Broad Transcriptomic Impact of Sorafenib and Its Relation to the Antitumoral Properties in Liver Cancer Cells.
Contreras L; Rodríguez-Gil A; Muntané J; de la Cruz J
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267509
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1.
Dong ZB; Wu HM; He YC; Huang ZT; Weng YH; Li H; Liang C; Yu WM; Chen W
Cell Death Dis; 2022 Jan; 13(1):35. PubMed ID: 35013144
[TBL] [Abstract][Full Text] [Related]
18. Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib.
Fondevila F; Méndez-Blanco C; Fernández-Palanca P; Payo-Serafín T; van Pelt J; Verslype C; González-Gallego J; Mauriz JL
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769197
[TBL] [Abstract][Full Text] [Related]
19. Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor.
Lendvai G; Szekerczés T; Illyés I; Csengeri M; Schlachter K; Szabó E; Lotz G; Kiss A; Borka K; Schaff Z
PLoS One; 2021; 16(6):e0253065. PubMed ID: 34129628
[TBL] [Abstract][Full Text] [Related]
20. PERK/ATF4-Dependent ZFAS1 Upregulation Is Associated with Sorafenib Resistance in Hepatocellular Carcinoma Cells.
Lin JC; Yang PM; Liu TP
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
